Our recent publication on efficacy of AT2R agonist LP2 in CRC is now available online. This work shows how PCDA may support your pre-clinical program for a novel molecule in oncology. https://pubmed.ncbi.nlm.nih.gov/36493954/
Meet us at 11th Drug Discovery Strategic Summit (DDSS) in Amsterdam on November 10-11 and learn about PCDA services. Let’s talk smart – schedule a meeting with us. https://drugdiscoverystrategicsummit.com
I am proud to announce the launch of the new website! I hope that the new design will allow you to find the information you need more quickly and easily. I am continuing to update the website with useful information and news regarding the company and activities, so please do check back for updates. Please …
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’sLorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’sLorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’sLorem Ipsum is simply …
I am pleased to announce our newest paper in the European Journal of Haematology is now published online! Lanthipeptide LP2 exerts myeloprotective and myeloregenerative actions after treatment with 5-fluoruracil in vivo. https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.13927
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’sLorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’sLorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’sLorem Ipsum is simply …